AIRLINK 74.25 Decreased By ▼ -0.04 (-0.05%)
BOP 4.92 Decreased By ▼ -0.03 (-0.61%)
CNERGY 4.33 Decreased By ▼ -0.04 (-0.92%)
DFML 39.30 Increased By ▲ 0.50 (1.29%)
DGKC 85.02 Increased By ▲ 0.20 (0.24%)
FCCL 21.25 Increased By ▲ 0.04 (0.19%)
FFBL 33.79 Decreased By ▼ -0.33 (-0.97%)
FFL 9.70 No Change ▼ 0.00 (0%)
GGL 10.48 Increased By ▲ 0.06 (0.58%)
HBL 112.70 Decreased By ▼ -0.30 (-0.27%)
HUBC 136.75 Increased By ▲ 0.55 (0.4%)
HUMNL 11.92 Increased By ▲ 0.02 (0.17%)
KEL 4.73 Increased By ▲ 0.02 (0.42%)
KOSM 4.45 Increased By ▲ 0.01 (0.23%)
MLCF 37.79 Increased By ▲ 0.14 (0.37%)
OGDC 136.86 Increased By ▲ 0.66 (0.48%)
PAEL 25.26 Increased By ▲ 0.16 (0.64%)
PIAA 19.88 Increased By ▲ 0.64 (3.33%)
PIBTL 6.65 Decreased By ▼ -0.06 (-0.89%)
PPL 122.07 Decreased By ▼ -0.03 (-0.02%)
PRL 26.68 Increased By ▲ 0.03 (0.11%)
PTC 13.83 Decreased By ▼ -0.10 (-0.72%)
SEARL 57.68 Increased By ▲ 0.46 (0.8%)
SNGP 67.29 Decreased By ▼ -0.31 (-0.46%)
SSGC 10.30 Increased By ▲ 0.05 (0.49%)
TELE 8.36 Decreased By ▼ -0.04 (-0.48%)
TPLP 11.15 Increased By ▲ 0.02 (0.18%)
TRG 63.10 Increased By ▲ 0.29 (0.46%)
UNITY 26.46 Decreased By ▼ -0.04 (-0.15%)
WTL 1.37 Increased By ▲ 0.02 (1.48%)
BR100 7,809 Decreased By -1.1 (-0.01%)
BR30 25,201 Increased By 50.8 (0.2%)
KSE100 74,914 Decreased By -42.8 (-0.06%)
KSE30 24,075 Decreased By -8.2 (-0.03%)
Markets

Wall Street ends mixed as new aid deal remains elusive

    • Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44.
Published August 11, 2020

NEW YORK: Wall Street ended Monday's trading session the way it started: mixed, with Nasdaq retreating again as investors eye uncertain data and an elusive deal on a new emergency spending package.

At the closing bell on the first trading session of the week, the tech-rich Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44 and the broad-based S&P 500 rose 0.3 percent to finish at 3,360.47.

The only data reports released Monday both offered information on the state of the pandemic-ravaged US jobs market, but one was from June, before COVID-19 cases began to resurge, taking the total past five million.

The other, the Conference Board's Employment Trends Index, showed a slight improvement in July but nonetheless confirmed the grim outlook.

The index is down 53.8 percent from a year ago, and Gad Levanon, head of The Conference Board Labor Markets Institute, warned that in coming months "job growth will significantly put on the brakes, likely causing the national unemployment rate to remain in double-digit territory."

What form a new spending package will take remained in doubt as the White House and Democratic leaders in Congress traded barbs and blaming each other for the failure to reach agreement.

President Donald Trump signed four executive orders over the weekend including one to defer payroll taxes, and another to provide $400 in weekly unemployment benefits, $100 of which will be paid by already cash-strapped states, to replace the $600 weekly payments that expired at the end of July.

Senator Chuck Schumer, the lead Democrat in the upper house of Congress, called Trump's efforts "laughable," while Treasury Secretary Steven Mnuchin called the Democratic proposal for aid to state and local governments "absurd."

But Peter Cardillo of Spartan Capital Securities told AFP: "The market is ignoring negative factors.

"It continues to move on higher on hopes of the recovery gaining traction."

McDonald's slipped 0.2 percent after the company announced it was suing former CEO Steve Easterbrook to recover compensation after discovering he lied "and destroyed information" about relationships with three other employees, and gave stock worth hundreds of thousands of dollars to one of the employees.

Marriott International missed earnings expectations but still jumped 3.6 percent on the upbeat outlook, while MGM Resorts surged nearly 14 percent after announcing a $1 billion investment.

But Kodak plunged 28 percent after a US agency suspended a loan intended to support the former photo giant's launch of a new pharmaceutical venture following controversy that has surrounded its July 28 announcement about the $765 million loan.

Comments

Comments are closed.